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Abstract
The adhesion of bacterial pathogens to host cells is an event that determines infection, and ultimately invasion and
intracellular multiplication. Several evidences have recently shown that this rule is also truth for the intracellular pathogen
Brucella. Brucella suis displays the unipolar BmaC and BtaE adhesins, which belong to the monomeric and trimeric
autotransporter (TA) families, respectively. It was previously shown that these adhesins are involved in bacterial adhesion to
host cells and components of the extracellular matrix (ECM). In this work we describe the role of a new member of the TA
family of B. suis (named BtaF) in the adhesive properties of the bacterial surface. BtaF conferred the bacteria that carried it a
promiscuous adhesiveness to various ECM components and the ability to attach to an abiotic surface. Furthermore, BtaF
was found to participate in bacterial adhesion to epithelial cells and was required for full virulence in mice. Similar to BmaC
and BtaE, the BtaF adhesin was expressed in a small subpopulation of bacteria, and in all cases, it was detected at the new
pole generated after cell division. Interestingly, BtaF was also implicated in the resistance of B. suis to porcine serum. Our
findings emphasize the impact of TAs in the Brucella lifecycle.
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Introduction
Species from the Brucella genus are Gram negative bacteria,
facultative intracellular pathogens responsible for brucellosis, a
zoonotic disease that affects several terrestrial and marine
mammals, including livestock [1]. Brucella abortus, Brucella melitensis,
and B. suis are the most economically significant species of the
group, since their preferred hosts are cattle, caprine, and swine,
respectively. Brucellosis causes abortion and infertility in animals.
In humans it may lead to a severe debilitating disease [2]. Human
brucellosis is acquired either through consumption of contami-
nated dairy products or by coming into contact with infected
animal secretions [3,4].
When brucellae are ingested or inhaled, they cross the mucosal
surfaces and are transported to the lymph nodes by phagocytic
cells. The spread and multiplication in lymph nodes, liver, spleen,
bone marrow and other tissues occur via macrophages [5,6].
During the onset of the infection, Brucella is able to resist the killing
action of several bactericidal substances, including the comple-
ment present in serum [7,8]. It was proposed that Brucella
lipopolysaccharide hampers the binding of complement activating
components to the bacterial surface [9]. It is accepted that a low
activation of the innate immunity for a long incubation period
opens an immunological window that gives the opportunity to
brucellae to spread throughout the reticuloendothelial system and
establish the intracellular replication niche. After this long
incubation period, a strong adaptive immunity is induced and
the clinical symptoms are evident [5]. The virulence of Brucella spp.
depends on their ability to replicate and survive within macro-
phages and other host cells, including epithelial cells, in a
compartment derived from the endoplasmic reticulum
[10,11,12,13].
Intracellular pathogens must bind to the cells or other host
components to successfully infect the host. Bacteria use a great
variety of tools to adhere and eventually invade the host cell,
ranging from multimeric complexes, such as pili or fimbria, to
monomeric or oligomeric proteins. Bacterial adhesins mediate the
initial interaction with the host by recognition of different host
molecules, including components of the extracellular matrix
(ECM), integrins or integral host membrane proteins [14]. B.
abortus and B. melitensis bind to HeLa and macrophages cells with a
characteristic kinetics. It was suggested that this process is
mediated by host cell molecules rich in sialic acid residues through
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the Brucella surface UgpB protein [15,16]. Brucella also interacts
with components of the ECM such as fibronectin [15]. We have
identified by phage display a large fibronectin-binding protein of
340 kDa (BmaC) from B. suis, which belongs to the monomeric
(type I) autotransporter family. Members of this family are
extracellular proteins that contain a C-terminal b-barrel domain
responsible for the translocation of the functional domain across
the outer membrane [17,18]. We demonstrated that BmaC is
involved in the binding of B. suis to non-phagocytic cells, such as
HeLa and A549 epithelial cells, through interaction with cellular
fibronectin [19]. We have recently identified BtaE, a member of
the type II (trimeric) autotransporter family, which was shown to
contribute to the adhesion of B. suis to hyaluronic acid and
epithelial cells, and was necessary for full virulence in mice [20].
Members of the trimeric autotransporter (TA) family also have the
information in the C-terminal region for their own translocation
through the outer membrane but to do so they form trimeric
structures on the bacterial surface [17]. Remarkably, we found
that both, the BmaC and BtaE adhesins are associated exclusively
with the new cell pole, suggesting that this pole in Brucella is
specialized for adhesion [20]. Besides, these findings support the
concept that bacterial polarity is an important feature of Brucella
physiology [21,22,23].
In silico analysis led to the identification of a second protein of
the TA family, which we named BtaF. Through heterologous
expression and mutational approaches we show that BtaF plays a
role in the adhesive features of the Brucella cell surface. Our
observations suggest that some of BtaE and BtaF functions
partially overlap while others are distinctive of BtaF. In fact, BtaF
(but not BtaE) confers resistance to complement activity.
Interestingly, both adhesins are required to achieve full infectivity
in the mouse model.
Materials and Methods
Ethical statement
Animal procedures and management protocols were approved
by the Animal Welfare and Ethics Committee according to
Animal Welfare Policy (Act 087/02) of the Faculty of Veterinary
Medicine (Universidad Nacional del Centro de la Provincia de
Buenos Aires, Tandil, Argentina; http://www.vet.unicen.edu.ar).
Bacterial strains, cell culture and media
E. coli strains used in this study (DH5a, K12 and derivatives)
were grown at 37uC in Luria Bertani (LB) medium. Antibiotics
were added when needed: ampicillin (200 mg/ml), chloramphen-
icol (50 mg/ml), and tetracycline (5 mg/ml). B. suis M1330 [ATCC
23444] and derivative strains were grown at 37uC in Bacto Tryptic
Soy Broth (TSB, Bacto). When necessary antibiotics were added:
chloramphenicol (6 mg/ml), kanamycin (50 mg/ml) and nalidixic
acid (10 mg/ml). HeLa cells and lung epithelial A549 (ATCC CCL
185) cells were cultured in DMEM (GIBCO), and murine J774
macrophages in RPMI (GIBCO) media; both supplemented with
5% foetal calf serum (PAA), at 37uC in a 5% CO2 atmosphere.
Molecular techniques
All DNA manipulations were carried out by using standard
procedures. Sequencing was done by cycle sequencing performed
with a BigDye kit (Applied Biosystems) in a 3130 Genetic Analyzer
(Applied Biosystems). Sequence data of B. suis genome [24] was
obtained from the Brucella Bioinformatical Portal (BBP) website
(http://www.phidias.us/bbp/data/). PCR primers containing
added restriction enzymes were designed to amplify the flanking
regions of btaF. Primers F1 (59 GGGCATGCTGTTCTGGA-
CAGGCGTAGCTG 39) and R1 (59 CGCTGCAGCTCCG-
CCTTCGCAGCGTCG 39) amplified a region of 371 pb
upstream btaF; and primers F2 (59 GCCTGCAGCATGGCA-
TAATATGCACCCG 39) and R2 (59 CGGGATCCACCCAGA-
CATCGCCGCCGC 39) a region of 379 pb downstream the gene.
New restriction sites are underlined. The generated PCR
fragments were purified, cleaved with the corresponding enzymes,
ligated together, and cloned into the pK18mobsacB mobilizable
suicide vector (Km resistant) [25] obtaining pKmobsacDbtaF
plasmid. This plasmid was conjugated into a nalidixic resistant-
derivative of the wild type strain B. suis M1330 and double
recombinant clones were selected (NalR, KmS, sucrose resistant).
The clean deletion of the entire open reading frame was confirmed
by PCR, and the absence of BtaF was confirmed by Western blot.
The btaF gene (including its own promoter) was cloned into the
pBBR1MCS-1 broad host range cloning plasmid [26]. A region of
1645 pb containing 631 pb of the upstream region, the btaF ORF
and 177 pb corresponding to the downstream region was
amplified using the following primers: FComp (59 CTGGTAC-
CAGCGCTGGTGCAGAAGGTGATAGAC 39) and RComp
(59 CTGAGCTCCAATGCCCGCATGTGACGTTGCAAT 39).
New restriction sites are underlined. The amplified product was
cloned into the pBBR1MCS-1 vector [27] resulting in the
pBBRbtaF plasmid, which was conjugated into B. suis DbtaF.
Transconjugants were selected (CmR) and confirmed by PCR. E.
coli K12 was transformed with pBBRbtaF or empty pBBR1MCS-1
vector as control. Transformed clones were selected (CmR) and
confirmed by PCR.
In silico analysis
Protein domains were analysed with Pfam [28], BLAST [29],
and daTAA [30], which is specific for trimeric autotransporters.
Secretion signal was identified with SignalP Server [31]. Align-
ments of the proteins were made with ClustalX (1.81) [32].
Binding to host components
The affinity of BtaF-expressing bacteria to ECM components
and fetuin (as a compound rich in sialic acid) was performed as
described elsewhere [33]. Briefly, 96-well plates (Nunc Maxisorp)
were coated overnight at 4uC with 50 ml of 100 mg/ml solutions of
the ligand and dissolved in phosphate buffered saline (PBS).
Bacteria were grown overnight, washed, and resuspended in PBS
to a final concentration of 16109 colony forming units (CFU)/ml
(OD = 1 for E. coli and OD = 0.2 for Brucella). Wells were washed
three times with 100 ml of PBS to eliminate unbound ligand.
Then, 50 ml of bacterial suspensions were added to each well and
incubated at 37uC for 3 hours. After incubation, wells were
washed three times with PBS to remove non-adherent bacteria,
and adherent bacteria were harvested with trypsin-EDTA (0.05%
trypsin (GibcoH) 20.5% EDTA (USB). After incubating for 10
minutes at 37uC, serial dilutions were done, plated on LB or TSB
agar with the appropriate antibiotic, and CFU were determined.
Attachment to abiotic surfaces
Bacterial attachment to wells of polystyrene (PE) plates was
assayed based on previous protocol [34]. Briefly, starter cultures
were grown in appropriate media overnight and diluted on fresh
media (1:1000); then 150 ml of these diluted cultures were seeded
in the wells of PE 96-well flat bottom culture plates (Cellstar,
Greiner Bio One). These plates were then cultured at 37uC for
24 hours with agitation. Unbound bacteria were removed by
gently washing the wells three times with NaCl 0.9%, and attached
bacteria were quantified by staining with 0.1% (w/v in water)
crystal violet (CV) (Acros Organics, Geel, Belgium). Optical
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density was measured at l= 595 nm in a Microplate Reader
(DTX 880 multimode detector, Beckman Coulter).
Autoagregation
Bacteria were cultured overnight on appropriate media at 37uC
with agitation. Then a dilution was carried on (1:100) and cells
were grown overnight. The cultures were left at room temperature
without agitation. At different time points the percentage of the
tube that had bacteria in suspension was measured.
Antibodies
Polyclonal antiserum was obtained by immunization of mice
with a peptide corresponding to BtaF passenger domain (Fig. 1,
underlined region). The coding sequence was amplified using the
primers FAb (59CCCATATGCTAATTAGTGAAAATAGG-
CAAG 39) and RAb (59CAGTCGACTCCGGCACGTGCCTC
39), and cloned into pET28a (Novagen). New restriction sites are
underlined. The recombinant peptide was purified by HPLC and
then separated by sodium dodecyl sulphate (SDS)-PAGE from
other proteins. The band corresponding to the peptide was cut
from the gel and then lyophilized. The powder was resuspended in
sterile PBS and then used for immunization of five C57/BL6 male
mice. Animal procedures were performed in compliance with
institutional, as well as governmental, rules and regulations.
Western blot
Total proteins from both Brucella and E. coli strains were
separated on a semi-native gel, based on a protocol previously
described [35]. Proteins from the extracellular medium of Brucella
were also analysed; 50 ml of cultured bacteria were centrifuged to
separate supernatant (containing secreted compounds) from
bacterial cells. Extracellular proteins were precipitated with 10%
trichloroacetic acid, and resuspended in sample buffer (see below).
The cell pellet fraction was resuspended in cold 20 mM Tris-HCl
buffer (pH 8.0), 1 mM phenylmethylsulfonyl fluoride (PMSF) and
disrupted using Precellys (Bertin technologies). This homogenate
was kept on ice (or at 220uC for storage). Then one volume (1:1)
of sample buffer (20 mM Tris pH 8, 2 mM EDTA pH 8, 40%
sucrose, 0.02% bromo phenol blue, 0.05% SDS for E. coli or 0.1%
for B. suis) was added and incubated for few minutes on ice. Next,
samples were subjected to 10% polyacrylamide gel electrophoresis,
which was carried out at 4uC to prevent protein denaturation.
Resolved proteins were transferred to PDVF membranes (GE
Healthcare), blocked overnight with TBS 5% milk powder (w/v) at
4uC with gentle agitation. Blots were probed with the polyclonal
mice anti-BtaF serum (1:300 for E. coli, and 1:800 for Brucella) and
a goat HRP-conjugated secondary anti-mouse antibody (1:30.000,
Santa Cruz). Finally, blots were revealed using ECL Plus
(Amersham). BtaF antiserum was pre-adsorbed with an E. coli
extract carrying the empty pET28a vector or B.suis DbtaEDbtaF.
Immunofluorescence
Brucella was transformed with a derivative of pBBR1MCS-2
[26,27], which carries gfp constitutively expressed (excitation at
488 nm, emission at 509 nm, filters used BP 505–530) [19]. The
strains carrying polar markers fused to fluorescent proteins were
obtained as previously described by biparental conjugation with E.
coli S17.1 strains carrying either pdhS-egfp [21] or aidB-yfp [36]. E.
coli strains were transformed with the plasmid pHC60 [37] which
carries gfp constitutively expressed. BtaF was detected by immnu-
fluorescence using anti-BtaF antibodies (see above) as previously
described [20].
Cell infection assays
Infection assays were carried out as previously described [20].
Briefly, HeLa (ATCC CCL2, human epithelial carcinoma cell
Figure 1. BtaE and BtaF domain organization. Schematic representation of BtaE and BtaF showing functional and structural domains predicted
by bioinformatics (SignalP, Pfam, BLAST and daTAA), and the fragment of the protein used for antibody production (underlined region). Numbers
indicate amino acid positions within the adhesin.
doi:10.1371/journal.pone.0079770.g001
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line), A549 (ATCC CCL185, human lung epithelial cells) or
murine macrophages (J774) cell lines were seeded in 24-well plates
and inoculated with the different strains (multiplicity of infection
100:1). Total bacteria associated with the cells were determined by
lysis with 0.1% Triton X-100, after 1 hour or 45 minutes (in the
case of macrophages) of incubation and plating serial dilutions. To
quantify the number of intracellular viable bacteria a standard
gentamicin protection assay was performed. The number of
adherent bacteria was calculated as the difference between total
bacteria associated to the cells and intracellular bacteria. A similar
procedure was performed to evaluate adhesion of recombinant E.
coli to HeLa cells.
Virulence in BALB/c mice
Six to eight weeks-old female BALB/c mice were purchased
from the animal facility from Leloir Institute. They were randomly
distributed in experimental groups at least 1 week before being
inoculated. The animals were housed in a filter-ventilated
containment in the Laboratory Animal Facility of the Facultad
de Ciencias Veterinarias (Tandil) receiving water and food ad
libitum. All experimental protocols were performed by the premise
of minimizing the suffering to which animals are exposed and
using the minimum number of experimental animals to ensure
statistically significant results. BALB/c mice (10 per group) were
inoculated by intragastric delivery of wild type B. suis 1330
(1.356108 CFU/mouse), and its isogenic derivative strains DbtaE
(1.296108 CFU/mouse), DbtaF (1.346108 CFU/mouse), DbtaF
pBBRbtaF (1.276108 CFU/mouse) and DbtaEDbtaF (1.486108
CFU/mouse), suspended in 300 ml of 10% sodium bicarbonate by
use of a plastic feeding tube introduced through the mouth. Five
mice from each group were sacrificed at 7 and 30 days
postinfection (p.i.), and spleens were removed. Dilutions of spleen
homogenates were plated in duplicate on TSA. After 4 days of
incubation, CFU were counted and expressed by the log10 value
per spleen. The CFU data were normalized by log transformation
and evaluated by ANOVA followed by Dunnett’s post hoc test
(Prism 5.0; GraphPad Software, Inc.). The experiment was
repeated twice with similar results.
Serum resistance
A serum resistance test was performed as previously described
[38]. Briefly, bacteria were grown in appropriate media at 37uC
until early-logarithmic phase (OD at 600 nm of 0.3–0.5). Then the
bacteria were washed with PBS-MgCl2 5 mM and resuspended in
the same buffer. A dilution was made with the same buffer to
obtain a suspension of an OD of 0.01 at 600 nm. Cells were
incubated at 37uC in porcine serum (8% for E. coli strains and 50%
for B. suis strains). After 0 and 60 (for E. coli) or 90 minutes (for B.
suis) serial dilutions were plated to determine the CFU, and the
percentage of surviving bacteria, relative to the control strains
(100%) was calculated. As a control, complement was inactivated
by incubating the serum at 56uC for 30 minutes [39]. The killing
experiment was repeated in triplicate three times with similar
results.
Evaluation of antibody response by Enzyme-Linked
Immunobsorbent assay (ELISA)
96 well ELISA microplates (Greiner bio-one REF655061) were
covered with inclusion body fractions of E. coli pBBRbtaE [20], E.
coli pBBRbtaF or E. coli pBBR1MCS (as control). These
preparations were diluted in sodium carbonate buffer 0.06 M
pH 9 to a final concentration of 10 mg/ml, and incubated for two
hours at room temperature, with gentle agitation. Free sites were
blocked by incubating overnight at 37uC with PBS-casein 0.1%.
After washing with 0.05% PBS-Tween 20 (PBS-T), serum from
healthy or sick pigs donors (1:1000) was added and incubated
overnight at 4uC. After washing with PBS-T, Protein A/G-Calf
Intestinal Alkaline Phosphatase conjugated (Thermo Scientific,
1:5000) was added. The reaction was developed with 4-
nitrophenyl phosphate (Sigma). The resulting colour was read at
405 nm in a Microplate Reader (DTX 880 multimode detector,
Beckman Coulter). Values from control wells were subtracted from
the experimental samples prior to analysis to control for non-
specific binding. The reported data represent the results of sera
from 14 sick and 14 healthy pigs assayed each one in triplicate.
Data were analysed by Students test. Sera were kindly provided by
Sebastia´n Elena, Ana Marı´a Nicola and Cristina Franco from
Brucellosis Department, DILAB, Servicio Nacional de Sanidad y
Calidad Agroalimentaria (SENASA).
Results
BtaF, a new member of the TA family from B. suis
In silico analysis of putative adhesins of B. suis [20] showed that,
in addition to BtaE, another predicted protein corresponding to
BR_1846 displays the characteristic precursor domains of the TA
family [40,41,42,43]. Indeed, BR_1846 harbours a putative N-
terminal signal peptide with a predicted signal cleavage site
between the residues 29 and 30 (alanine and proline), a homologue
YadA-like C-terminal region [30], and an extension of 160–170
amino acids between both regions (Fig. 1), which corresponds to
the functional passenger domain. Therefore, we named BR_1846
as BtaF (for Brucella trimeric autotransporter). Analysis of the BtaF
passenger domain did not show the presence of conserved
adhesion motifs or any other domain (Fig. 1). In contrast, we
have previously shown that the passenger domain of BtaE
comprises several repetitions of two motifs associated with
adhesion (Fig. 1) [20]. Proteins of the TA family have been found
to display similar architectural structures, which consist of a
globular head, a connector, a stalk (corresponding to the passenger
domain) and an anchor domain (corresponding to the C-terminal
region), similar to a lollipop-shaped structure [44]. Using the TA
Domain Annotation (daTAA) server [30] we analysed the BtaF
passenger domain. This analysis only showed the presence of
several regions associated with the stalk (Fig. 1). Instead, no regions
corresponding to the head or the connector were predicted. Unlike
BtaF, we have previously shown that the BtaE passenger domain
harbours several domains associated with the globular head, the
connector and the stalk (Fig. 1) [20].
Interestingly, secondary structure prediction of the BtaF
passenger domain using Metaserver [45] suggested structural
similarity to an adhesion domain (PDB: 2qih_A) of the UspA1
adhesin, a TA from Moraxella catarrhalis [46].
BtaF orthologues were identified in the genomes of all the
species/strains of Brucella analysed (Table 1). Although a BtaF
homologue was not annotated in the genome of B. ovis ATCC
25840, an open reading frame encoding a full length protein was
identified. All the homologues display the characteristic (and
essential) functional domains of TAs. Interestingly, we found
significant differences between the different orthologues. The
protein length varies from 155 (for B. melitensis BMEI0205) to 437
amino acids (for B. microti) (Table 1). Furthermore, while the
passenger domains of several BtaF homologues (including that one
of the B. suis 1330 protein) do not display head domains, other
homologues display one or two of these domains. The percentage
of similarity of the passenger domains of the different orthologues
shared with that one of BtaF of B. suis 1330 varies from 67% (for
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BAB1_1854 from B. abortus 2308) to 96% (for B. pinnipedialis). To
note, while the passenger domains of the BtaF homologues of B.
suis strains 1330, VBI22 and 92/29 were highly conserved, the
passenger domain of the protein of B. suis bv. 3 str. 686 differs in
the presence of two head structural domains and was only 73%
similar to BtaF of 1330. Therefore, BtaF orthologous proteins
show variations not only among distinct Brucella species, but also
between different strains of the same species.
BtaF is involved in adhesion to ECM components and
abiotic surfaces
In order to study whether BtaF is involved in the adhesive
properties of the bacterial cell surface, a heterologous strategy and
a mutational approach were performed. The btaF gene with its
own promoter was cloned into the pBBR1MCS-1 vector to
generate pBBRbtaF. This plasmid was transferred to the non-
adhesive E. coli strain K12. Expression of BtaF in the heterologous
host was analysed by Western blot. Antibodies against a fragment
of the BtaF passenger domain (Fig. 1, underlined region) were
generated in mouse and purified by standard methods. Since
trimeric autotransporters are very difficult to denature (because
the C-terminal domains of TAs form heat and SDS-resistant
trimmers), we decided to solve these proteins on semi-native gel
electrophoresis to favour the trimeric form. Proteins were
immunodetected with anti-BtaF antibodies. A band corresponding
to BtaF was detected in E. coli carrying pBBRbtaF but was absent
in the control strain carrying the empty vector (Fig. 2A), indicating
that BtaF is expressed in the heterologous host. A knock-out
mutant strain of B. suis was generated by a clean deletion of the
btaF gene. Expression of BtaF in bacteria grown in TSB was
evaluated by Western blot as described above. All TAs charac-
terized so far remain associated with the cell surface. To confirm
this prediction, culture supernatants and whole-cell fractions of the
wild type and DbtaF mutant strains were analyzed by gel
electrophoresis and Western blot. A protein band recognized by
the anti-BtaF antibodies was observed in the whole-cell fraction of
the wild type strain, while this band was absent in the same
fraction of the mutant (Fig. 2B). Instead, BtaF was not detected in
the culture supernatants of the wild type or the mutant. These
observations indicate that BtaF is expressed by wild type bacteria
under conditions assayed and confirm that the passenger domain
remains bound to the bacterial surface.
We first analysed the ability of BtaF-expressing E. coli cells to
attach to hydrophobic surfaces in comparison with that of the
control strain that carries the empty vector. To this end, the
different strains were grown in a PE multiwell plate and attached
bacteria were estimated by CV staining. E. coli pBBRbtaF showed
a six-fold increase in the attachment to PE compared with the
control strain (Fig. 2C). In contrast, no differences were observed
in the binding to a hydrophilic glass surface between E. coli
pBBRbtaF and the control strain (data not shown). In line with
these observations, a significant decrease (by 56%) in the
attachment to PE of the DbtaF mutant compared with the wild
type strain was observed (Fig. 2D). The pBBRbtaF plasmid
restored attachment to the abiotic surface confirming the role of
BtaF in the formation of a biofilm in vitro. We have previously
shown that deletion of btaE does not affect bacterial attachment to
PE [20]. To test the possibility of overlapping functions between
BtaE and BtaF, we evaluated the attachment phenotype of a
double mutant DbtaE DbtaF. CV staining showed no significant
differences between the double mutant and the DbtaF single
mutant (data not shown), strongly suggesting that BtaF (but not
BtaE) participates in the formation of a biofilm in vitro.
The BmaC monomeric autotransporter mediates the binding of
B. suis to fibronectin [19]. Recent data showed that BtaE TA
contributes to the binding of B. suis to hyaluronic acid [20]. To test
the possibility that BtaF is also involved in the binding to
components of the ECM, we analysed the binding of E. coli
pBBRbtaF to different ECM components. We found that this
strain was able to bind more efficiently to several substrates such
as, collagen, hyaluronic acid, fetuin (a sialic acid rich protein) and
fibronectin, compared with the control strain (Fig. 2E). In
agreement with these observations, the B. suis DbtaF mutant
showed a significant decrease in the ability to bind collagen,
hyaluronic acid and fetuin compared with the wild type strain.
Table 1. Comparison of BtaF orthologues from different species and strains of Brucella.
Strain Locus Length (aa) daTAA annotation
a
Identity/Similarity of
passenger domainb
Head Stalk Connector Anchor
B. suis 1330 BR_1846 278 - 1 - 1 -
B. suis VBI22 BSVBI22_A1842 278 - 1 - 1 100/100
B. suis 92/29 C062_01978 311 - 1 - 1 99/100
B. suis bv. 3 str. 686 EEY31924 269 2 1 - 1 70/73
B. abortus 2308 BAB1_1854 197 2 2 - 1 65/67
B. abortus s19 BAbS19_I17340 257 2 2 - 1 72/74
B. melitensis bv. 1 16 M BMEI0205 155 - 1 - 1 84/85
B. canis ATCC 23365 BCAN_A1884 374 - 2 - 1 75/75
B. microti BMI_I1862 437 1 2 - 1 85/89
B. pinnipedialis BPI_I1902 311 - 2 - 1 95/96
B. ovis ATCC 25840 Presentc 195 - 1 - 1 92/93
aDomains as determined by daTAA (http://toolkit.tuebingen.mpg.de/data). Numbers of domains predicted to be part of the head, stalk, connector or anchor are
indicated.
bPercentage of Identity/Similarity shared with BtaF from B. suis 1330.
cLocus not annotated; a gene encoding a predicted full length protein homologue was identified between positions 1786495 and 1785911 (585 nucleotides) of
chromosome I.
doi:10.1371/journal.pone.0079770.t001
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Accordingly, wild type binding levels were restored by the
pBBRbtaF plasmid (Fig. 2F). The absence of a defective adhesion
phenotype of DbtaF towards fibronectin may be due to overlapping
functions between BtaF and other adhesins such as BmaC [19].
The phenotype of the DbtaF mutant may be due to a pleiotropic
effect on the bacterial surface. To evaluate this possibility we
assayed the resistance of the mutant to several toxic compounds,
which can be related to cell envelope composition. We found that
the DbtaF strain shows the same level of resistance to either 0.1%
Triton X-100, 0.1% SDS, 200 mg/ml EDTA, 0.1% sodium
deoxycholate or different concentrations of the cationic peptide
Polymyxin B compared with the wild type strain (not shown); thus,
the possibility that the btaF deletion causes a pleiotropic effect
seems unlikely.
Taken together, these results indicate that BtaF is involved in
the adherence to a variety of surfaces including a hydrophobic
abiotic surface, suggesting that a rather nonspecific adhesiveness is
conferred by BtaF. The possibility exists that a function of BtaF in
cell-to-cell interactions may account for these adhesive properties.
Since autoagglutination involves adhesion between bacteria, the
settlings kinetics of bacterial aggregates was studied in liquid
cultures of E. coli pBBRbtaF and the control strain. Yet, no
differences in the settlings kinetics between both strains were
observed. Furthermore, B. suis DbtaF showed no significant
differences in the autoagglutination kinetics compared with the
parental strain. Similarly, the B. suis DbtaE DbtaF double mutant
was not affected in autoaggregation (not shown). Therefore, it
seems that BtaF influences attachment to various immobilized
ligands and to hydrophobic surfaces mostly through direct
interaction with these surfaces.
Role of BtaF in adhesion to host cells
To evaluate whether BtaF contributes to adhesion to host cells,
the ability of E. coli expressing btaF to adhere and invade HeLa
cells was compared to that of the control strain. The number of
adherent bacteria was calculated as the difference between total
Figure 2. Role of BtaF in the adherence of B. suis to an abiotic surface and ECM components. Expression of BtaF was evaluated in E. coli
(A) and B. suis (B) strains by Western blot analysis. Total cell proteins and secreted proteins were separated on a semi-native gel (10%) and transferred
to PDVF membrane. Binding to the wells of PE microtiter plates (C and D) or to immobilized ligands (E and F) of E. coli pBBRbtaF and E. coli pBBR1MCS
(C and E), B. suis wild type, B. suis DbtaF and B. suis DbtaF pBBRbtaF (D and F) was assayed. Values correspond to the percentage of attachment to the
PE surface or percentage of binding to ECM components. A value of 100% was assigned to control strains. Data represent the means 6 and standard
deviations (SD) of the results of a representative experiment done in triplicate. Three independent experiments were performed with similar results.
Data were analyzed by Student’s t test and by one-way ANOVA followed by a Tukey a posteriori test. *, significantly different from control (P,0.05),
with 95% confidence.
doi:10.1371/journal.pone.0079770.g002
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cell-associated and intracellular bacteria. The E. coli strain
expressing BtaF showed a 51% increase in the number of
adherent bacteria (2,656105 CFU/ml) compared with the num-
ber of adherent bacteria (1.756105 CFU/ml) of the control strain
(considered as 100%), but no significant differences were found in
invasion or in the invasive/adherent ratio (Fig. 3A).
We next evaluated the effect of btaF deletion in the adhesion and
invasion of B. suis to HeLa cells. This cell line has been extensive
used as non-professional phagocytic cell model to study Brucella
internalization. In line with observations made by the heterologous
approach, the DbtaF mutant of B. suis showed a 45% reduction in
the adherent bacteria (3.516106 CFU/ml) compared with the
wild type strain (6.206106 CFU/ml), while adhesive levels were
restored in the complemented strain (Fig. 3B). Although the
mutant showed a 49% reduction in invasion compared with the
wild type, no significant differences in the invasive/adhesive ratio
were found between the mutant and the parental strain (Fig. 3B),
indicating that BtaF is involved in the initial attachment of B. suis
to HeLa cells rather than in cell internalization. To confirm these
findings, adhesion to human lung alveolar epithelial A549 cells was
assessed. The A549 cell line has been successfully used to study
initial stages of Brucella infection [19;20]. B. suis DbtaF showed a
69% reduction in the number of adherent bacteria
(2.156107 CFU/ml) compared with the wild type strain
(5.696107 CFU/ml) (Fig. 3C). Again, the reduction in invasion
was a consequence of a decrease adhesion since no differences
were observed in the invasive/adhesive ratio (Fig. 3C). As
expected, the complemented strain regained the wild type
adhesion phenotype.
We have recently shown that deletion of btaE reduces adhesion
of B. suis to HeLa and A549 cells to levels similar to those observed
in this work for the DbtaF mutant [20]. To evaluate possible
redundant functions of the TAs in the adhesion of B. suis to these
cells, the DbtaE DbtaF double mutant was also assayed. Surpris-
ingly, the double mutant showed similar levels of attachment to
both HeLa and A549 cells than the single mutants (data not
shown). A possible interpretation for this result might be that BtaE
and BtaF are implicated in the same adhesion mechanism to these
cell types.
Since infection of macrophages is crucial in the spread and
persistence of Brucella spp. in the infected mammal [5,6], we also
evaluated whether BtaE and/or BtaF contribute to adhesion or
invasion to professional phagocytes using as model the murine
macrophage cell line J774. We have previously shown that a
mutant defective in the BmaC adhesin is impaired in adhesion to
epithelial cells but not to macrophages [19]. Similarly, no
significant differences in adhesion, invasion or invasive/adhesive
ratio were found between the wild type strain, the DbtaF and DbtaE
single mutants or the double mutant (data not shown).
Finally, to test the possibility that the DbtaF mutant is affected in
intracellular survival, a classical intracellular proliferation assay
was carried out using macrophages and HeLa cells. In both cell
models, the wild type and the mutant strain showed the same
kinetics of intracellular replication (data not shown). Thus, similar
to BmaC [19] and BtaE [20], the absence of BtaF does not affect
later stages of cellular infection.
Surface-exposed unipolar localization of BtaF
Both, the monomeric BmaC autotransporter and the BtaE TA
display a surface unipolar localization. Interestingly, both proteins
were always detected at the new pole [20]. To assess the surface
presentation and localization of BtaF, late-exponential phase
cultures of B. suis wild type or the DbtaF mutant labelled with green
fluorescent protein (GFP) were refreshed for 1 h in TSB medium
and then fixed without permeabilization. By immunofluorescence
and confocal microscopy we found that BtaF was detected in 3–
4% of wild type bacteria examined, and in all cases (n = 50), the
red signal corresponding to BtaF exhibited unipolar localization.
In some cases the signal showed sub-polar localization (Fig. 4A). As
expected, no red signal was observed on the surface of the DbtaF
mutant but the unipolar signal was restored in the complemented
strain harbouring pBBRbtaF plasmid (data not shown). The BtaF
presentation and localization was also evaluated in E. coli
pBBRbtaF. The heterologous host carrying BtaF showed a red
signal in 4% of the population, and in all cells it was located at one
pole (Fig. 4B). No signal was observed in the control strain (data
not shown).
In order to determine whether BtaF is localized at a specific
pole, we used PdhS and AidB proteins as markers of the old and
new poles, respectively [21,36]. We observed that every time BtaF
(in red) was detected in bacteria carrying PdhS-eGFP protein
(green), it was localized at the pole opposite to PdhS (27
occurrences) (Fig. 4C), and it was never observed that BtaF and
PdhS co-localized. Instead, BtaF was at the same pole as AidB-
YFP (green) (40 occurrences) (Fig. 4D) or in cells with diffuse
marker, but never at the opposite pole. These results suggest that
similar to BmaC and BtaE, BtaF is localized at the new pole
generated after cell division. Thus, it appears that these adhesins
are expressed at one particular pole.
The BtaF adhesin contributes to serum resistance
The activation of the complement on the bacterial surface plays
a crucial role in the immune response against pathogens.
However, Brucella is rather inefficient to activate the complement
[7,8]. It was proposed that the particular structure of Brucella
lipopolysaccharide (LPS) reduces deposition of complement
activating components [7,8,9,47]. It has also been suggested that
other molecules may contribute to resistance to the bactericidal
activity of the complement [47]. As mentioned earlier, we found
that some portions of BtaF show structural similarity with the
UspA1 TA from M. catarrhalis. This pathogen interferes with the
classical complement activation pathway by binding the comple-
ment inhibitor C4BP to UspA1 and UspA2 [48,49]. Thus, we
wondered whether BtaF might be involved in resistance to the
complement present in porcine serum. To test this possibility, the
effect of btaF deletion on Brucella survival in the presence of 50%
porcine serum was analysed. Interestingly, the btaF mutant showed
a significant reduction (by about 53%) in survival compared with
the wild type strain, while the survival phenotype was restored by
the complementing plasmid (Fig. 5A). We have reported that
deletion of btaE does not affect serum resistance [20]. To rule out
overlapping effects, survival of the btaE btaF double mutant was
evaluated. Still, the double mutant exhibited a percentage of
survival in porcine serum similar to that of the single btaF mutant
(data not shown) suggesting that within the TAs, only BtaF is
involved in serum resistance.
To further investigate whether BtaF is directly involved in
serum resistance, survival in 8% porcine serum of E. coli strain
expressing BtaF was analysed. Since it is possible that porcine
serum contains antibodies against E. coli surface components,
serum killing of E. coli may proceed through antibody-dependent
or antibody-independent complement pathways. Interestingly, E.
coli pBBRbtaF showed more than ten-fold increase in the survival
percentage compared with the control strain (Fig. 5B). Instead,
both strains showed similar levels of survival in heat-inactivated
porcine serum (Fig. 5B), suggesting that BtaF is involved in the
resistance to complement-mediated serum killing.
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Figure 3. Adhesion and invasion to HeLa and A549 cells. Total numbers of adherent and intracellular (invasive) bacteria were determined, and
the invasive/adherent cell ratio was calculated. HeLa cells were infected with E. coli pBBRbtaF and E. coli pBBR1MCS (A). HeLa (B) and A549 (C) cells
were infected with B. suis wild type, B. suis DbtaF and B. suis DbtaF pBBRbtaF. Values are expressed relative to the control strains (E. coli pBBR1MCS or
the wild type strain of B. suis), defined as 100%. Values represent the means 6SD of the results of a representative experiment of three independent
assays done in triplicate. Data were analyzed by Student’s t test and by one-way ANOVA followed by a Tukey a posteriori test. *, significantly different
from control (P,0.05).
doi:10.1371/journal.pone.0079770.g003
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Antibody response to the Bta adhesins
To evaluate whether the TAs of B. suis are expressed in vivo
during the course of infection and if they are capable to induce an
immune response in the natural host, an indirect ELISA assay
using sera from 14 healthy and 14 sick donor pigs was performed.
We probed the different sera by ELISA with cell extracts obtained
from E. coli pBBR1MCS, E. coli pBBRbtaE or E. coli pBBRbtaF.
The optical density values corresponding to the control (E. coli
pBBR1MCS) extract was subtracted from the values correspond-
ing to the E. coli pBBRbtaE or E. coli pBBRbtaF extracts. The
average signal (measured as OD405nm) obtained for sera from sick
animals was significantly higher than that from healthy donors for
both BtaE and BtaF extracts (Fig. 6). These results suggest that the
TAs are expressed in vivo in the natural host and that in sick
animals these adhesins induce some antibody response.
BtaF is required for full virulence of B. suis in mice
To evaluate the impact of BtaF in the virulence of B. suis, we
used the mouse infection model. Groups of five mice were infected
by intragastric inoculation [50] and splenic infection was evaluated
at 7 and 30 days p.i., which represent early and stabilized infection
times [51]. We have previously shown that the DbtaE mutant
exhibits an attenuated phenotype [20]. To assess the overall
impact of TA adhesins in the B. suis virulence, the DbtaE DbtaF
double mutant and the DbtaE single mutant were also included in
the assay. At 7 days p.i. the splenic infection of B. suis DbtaF was
significantly reduced (by 0.71 log) compared with the wild type
strain, while the complemented strain recovered bacterial counts
(Fig. 7). A similar reduction in splenic infection was observed for B.
suis DbtaE (Fig. 7) [20]. Interestingly, at 7 days p.i. the DbtaE DbtaF
double mutant showed a further reduction (by 1.9 log) in splenic
Figure 4. BtaF localization. Detection of BtaF (in red) on the B. suis wild type surface (A) and on the E. coli pBBRbtaF surface (B) by
immunofluorescence of GFP-tagged bacteria. Cultures of GFP-labeled strains were fixed without permeabilization, incubated with anti-BtaF
antibodies, and then probed with a CY3-conjugated donkey anti-mouse antibody. Samples were observed with a Plan-Aprochromat 1006/1.4 oil DIC
objective on a Zeiss LSM 5 Pascal confocal microscope. Immunofluorescence microscopy using anti-BtaF antibodies of fixed cultures of B. suis strains
expressing Pdhs-eGFP (C) and AidB-YFP (D) as old and new pole markers, respectively. Samples were observed with a confocal LSM 510 Meta
microscope, using a Plan-Aprochromat 606/1.4 oil DIC objective. Representative images are shown. BtaF is indicated with red arrows, and pole
markers with green arrows. A schematic representation is presented. Lines indicate how the intensity profile (expressed in arbitrary units) was
constructed.
doi:10.1371/journal.pone.0079770.g004
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infection compared with the wild type (Fig. 7). At 30 days p.i. the
splenic infection of B. suis DbtaE and B. suis DbtaF single mutants
was reduced by 1.06 log and 1.22 log, respectively, while the
double mutant was reduced by 1.56 log, compared with the wild
type strain. Thus, at 30 days p.i., infection with the strain lacking
both btaE and btaF resulted in fewer CFU than the individual
DbtaE and DbtaF mutant strains. To note, this difference was not
statistically significant, probably due to dispersion of DbtaE DbtaF
double mutant data (Fig. 7).
These results show that BtaF is required for full virulence of B.
suis in mice infected through the oral route. The observation that
at 7 days p.i., fewer CFU were recovered from the spleen of mice
infected with the double mutant compared with the single mutants
suggests that both, the BtaE and BtaF adhesins, are required for a
full infective phenotype, especially at early stages of infection, and
that some of the BtaE and BtaF roles do not overlap.
Discussion
Initial adhesion to host components has proved to represent an
important event in the pathogenesis of several pathogens.
Evidence gained in recent years show that binding to the host
cell surface is also relevant for Brucella infection
[15,16,19,20,52,53,54]. In this work, we demonstrated that in
addition to the BmaC monomeric autotransporter and the BtaE
TA, a new member of the TA family, named BtaF, contributes to
the adhesive features of B. suis. While BtaE is a relatively large
protein of 740 amino acid residues and displays several predicted
adhesion motifs, BtaF is a rather small adhesin of only 278 amino
acid residues with no recognizable or characterized conserved
domains other than the C-terminal anchor domain. Besides,
although BtaF of B. suis only contains modules predicted to be part
of the ‘‘neck/stalk’’ (but no one characteristic of the ‘‘head’’), it is
clear that BtaF is able to function as an adhesin. In line with these
observations, some adhesive functions of the BadA TA from
Bartonella henselae were independent of the presence of the head
[55]. In addition, we have not found any significant protein
sequence similarity between the passenger domains of BtaF and
any other TA protein. Nevertheless, in silico analysis using
Metaserver [56] suggests significant structural homology of the
57–201 region of BtaF with the structure of the 527–665 region of
UspA1 (2qih_A), a TA from M. catarrhalis. It was proposed that this
UspA1 fragment mediates the binding of M. catarrhalis to the
human carcinoembryonic antigen-related cell adhesion molecule 1
(CEACAM1) receptor [46]. It will be interesting to evaluate
Figure 5. BtaF is involved in resistance to porcine serum. Early logarithmic phase cultures were used to evaluate resistance to porcine serum
of B. suis (A) and E. coli (B) strains. Survival after one hour of incubation in serum with complement activity was evaluated and then expressed as
survival percentage (%) relative to wild type B. suis 1330 or E. coli pBBR1MCS-1, defined as 100%. Total CFU/ml are also indicated in the right Y-axis for
Brucella survival (A). E. coli survival was also assessed in buffer and heated serum (B). Values represent the means6SD of the results of an experiment
representative of three independent assays done in triplicate. Data were analyzed by Student’s t test and one-way ANOVA followed by a Tukey a
posteriori test. *, significantly different from control (P,0.05).
doi:10.1371/journal.pone.0079770.g005
Figure 6. In vivo expression of BtaE and BtaF in pigs. Extracts from E. coli pBBRbtaE, E. coli pBBRbtaF and the control E. coli pBBR1MCS were
used to perform indirect ELISA using sera from healthy and sick pigs infected with Brucella. The values correspond to the means6SD of the results of
a representative experiment of three independent assays done in duplicate. Data were analyzed by Student’s t test. Values between healthy and sick
pigs were significantly different (P,0.001 for BtaE and P,0.05 for BtaF)
doi:10.1371/journal.pone.0079770.g006
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whether B. suis interacts with the CEACAM1 molecule and if this
is so, whether BtaF is involved in this interaction.
Our previous evidences showed that BmaC mediates the
binding of B. suis to fibronectin and in lower degree to collagen,
and that BtaE is involved in the binding to hyaluronic acid
[19,20]. In contrast to these adhesins, BtaF confers affinity to
several surfaces, including ECM components and a hydrophobic
abiotic surface. In effect, BtaF expression in a ‘‘non-adherent’’ E.
coli strain was found to greatly increase the binding of recombinant
bacteria to all these surfaces. Analysis of the adhesion phenotypes
of the knockout btaF mutant confirmed these observations. Thus,
BtaF confers a promiscuous adherence to several surfaces. A
similar observation was made for the BadA autotransporter from
the closely related Bartonella henselae. In this case, it was proposed
that the higher is the number of neck motifs within the passenger
domain, the greater is the affinity of the BadA homologue/variant
to several ligands [55].
The ability to develop microcolonies or a biofilm on host
surfaces could influence bacterial invasion to host cells. We have
previously shown that neither of the BmaC and BtaE adhesins are
involved in the formation of a biofilm in vitro or in the ability of B.
suis to autoaggregate [19,20]. We found that heterologous
expression of BtaF in E. coli greatly increased the formation of a
biofilm biomass on a hydrophobic abiotic surface. Accordingly,
the B. suis btaF mutant was impaired in biofilm formation. The
development of a biofilm depends on both, the initial attachment
to the surface, and cell-to-cell interactions. However, our
observations suggest that BtaF is not involved in cell-to-cell
interactions. We can conclude that BtaF participates in bacterial
attachment to several surfaces.
We showed that at least three adhesins of B. suis (BmaC, BtaE
and BtaF) are required to observe a wild type adhesion phenotype
to epithelial cells. While inactivation of bmaC reduces the
adherence of B. suis to host cells by 2 log, deletion of either btaE
or btaF consistently diminishes the binding of B. suis by about 50–
60%. This suggests a more critical role of BmaC in the adherence
to cultured cells. Intriguingly, the double mutant btaE btaF
behaved in vitro similarly to the single mutants. Thus, we can
hypothesize that BtaE and BtaF TAs might be part of the same
‘‘adhesion pathway’’ to cultured epithelial cells, each one fulfilling
different and complementary functions. Further studies are
necessary to understand the interplay between these two adhesins
in the binding to host cells.
Brucella prevents detection by complement [7,57,58]. It was
proposed that the distinctive structure of Brucella LPS reduces
deposition of complement components [8,9,47]. Interestingly, it
was proposed that other surface factors mediate the varied
sensitivity of Brucella species to the bactericidal action of serum.
In effect, rough strains of B. melitensis were shown to bind less
complement than rough B. abortus strains. In other words, it seems
that the presence of a particular exposed LPS on the bacterial
surface cannot be the only factor causing the inhibition of binding
of complement components observed in the more virulent
organisms [47]. Our observations suggest that BtaF might be an
additional factor involved in protecting B. suis cells from killing by
the complement. In contrast, BmaC and BtaE were found not to
participate in resistance to complement [19,20]. Although
previous evidence suggests that the alternative pathway is not
activated by smooth or rough strains of B. abortus and B. melitensis
strains, it was proposed that the classical and the lectin pathways
mediate complement deposition and complement-mediated killing
of Brucella. It was suggested that both, mannose binding lectin
(MBL) and C1q (the first subcomponent of the classical
complement pathway), initiate antibody-independent complement
activation and killing of O-antigen-defective strains [47]. There-
fore, BtaF may be involved in the inhibition of this activation
mechanism. Another possibility is that B. suis, in contrast to B.
abortus and B. melitensis, is able to activate to some extent the
complement through the alternative pathway and therefore, BtaF
somehow inhibits this pathway. Several surface proteins, including
adhesins of the TA family were shown to be involved in serum
resistance of other pathogens. Bordetella pertusis expresses several
factors during the virulence phase that interact with complement
components or its regulators, either directly or indirectly and
Figure 7. Both, BtaE and BtaF, are required for full virulence of B. suis in mice. BALB/c mice were inoculated with the B. suis strains by
intragastric delivery, sacrificed at 7 and 30 days p.i., and spleens were removed. Dilutions of spleen homogenates were plated and CFU were counted
and expressed as the log10 value per spleen. The CFU data were normalized by log transformation and evaluated by one-way ANOVA followed by
Tukey’s a posteriori test. The experiment was repeated twice with similar results. *, significantly different from the wild type (P,0.05); ** Significantly
different from wild type and simple mutants (P,0.05).
doi:10.1371/journal.pone.0079770.g007
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thereby mediating resistance to complement [59]; some of them
are the BrkA [60] and the Vag8 [59] autotransporters. As
mentioned earlier, the UspA2 TA from Moraxella catharralis was
found to be involved in serum resistance [61]. Additional
experiments will be carried out to understand the underlying
molecular mechanism involved in BtaF-mediated serum resis-
tance.
Several evidences demonstrate that polarity is an important
feature of Brucella and other a-proteobacteria [20,21,23,36]. In
fact, it was observed that individual Brucella interacts with the host
cell surface through one of its poles [19,62], and we determined
that BmaC and BtaE are localized to the new pole generated after
cell division [20]. Similar to BtaE and BmaC, under the conditions
assayed, Brucella expressed BtaF in a low proportion of cells, and in
all cases it was localized at the new pole. Evidence reported here
for BtaF reinforces the hypothesis that the new pole generated
after an asymmetric division [23] is differentiated for adhesion to
surfaces [20]. As discussed in a previous publication, it is possible
that the low proportion of cells that show a detectable fluorescent
foci corresponding to the adhesin is due to one or the combination
of several reasons, such as, low expression in vitro of bma or bta
genes, and the adhesin is only expressed in a subpopulation of
bacteria depending on the bacterial cell cycle stage [21,23]. It is
interesting to speculate that this subpopulation might bind more
efficiently to host cells. Curiously, it was proposed that other a-
proteobacteria, such as Caulobacter crescentus and Agrobacterium
tumefaciens display adhesive structures on the opposite pole, i.e.,
the old pole generated after an asymmetric division [23,63,64]. As
we previously discussed, it is possible that this difference might be
related to the sessile mode of life of these bacteria, in comparison
with the transient adhesion of Brucella to the host cell surface [20].
Deletion of btaF reduced by about 1 log the CFU recovered
from spleen at early stages of mice infected by intragastric
inoculation. This attenuation was similar to that observed for the
btaE mutant [20]. Interestingly, at 7 days p.i., the btaE btaF double
mutant established a splenic infection that was significantly
reduced compared with the single mutants. Thus, although the
double mutant behaved similarly to the single mutants in cultured
cells, absence of both proteins results in a more severe phenotype
in vivo compared with the attenuation observed for the single
mutants. A possible interpretation for this result is that the
phenotype of the double mutant in vivo is a consequence of a defect
in more than one function of BtaF in addition to those of BtaE. As
mentioned earlier, it is possible that some of the roles might be
shared or complementary between BtaE and BtaF, while others
could be exclusive of BtaF or BtaE, for example the role of BtaF in
serum resistance.
In an effort to evaluate whether the two TAs of B. suis are
expressed in vivo in the natural host, the presence of antibodies
anti-BtaE and anti-BtaF in healthy and sick pigs infected with B.
suis was evaluated by an indirect ELISA assay. This analysis
suggests that both TAs are expressed in vivo in swine, which
reinforces the significance of these adhesins in the infection
process. Further studies are required to evaluate the immunoge-
nicity strength of the adhesins.
It is important to mention that similarly to BmaC [19] and BtaE
[20] orthologues, we also found significant variations in size and
domain architecture of the passenger domains of the different BtaF
orthologues, not only among different species but also between
different strains of the same species (Table 1). An attractive
hypothesis is that BtaF and the other adhesins are host preference
markers that contribute to tissue tropism of Brucella spp. in their
primary hosts.
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